Aclarion (ACON) Shares Outstanding (Weighted Average) (2021 - 2026)
Aclarion (ACON) reported Shares Outstanding (Weighted Average) of $2.1 million for Q1 2026, up 870.92% on a YoY basis from $219366.0 in Q1 2025, and up 7506.68% quarter-over-quarter from $28000.0 in Q4 2025.
Aclarion (ACON) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends
Aclarion has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 870.92% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 870.92% YoY), and the FY2025 full-year result was $28000.0, up 2869.25% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $2.1 million, up from $28000.0 in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $5.5 million in Q3 2022, with the low at $62.0 in Q4 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $948708.3 across 5 years, with a median of $461341.0 in 2025.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) plunged 99.98% — and 2025, when it jumped 64037.78%.
- Aclarion's Shares Outstanding (Weighted Average) stood at $381598.0 in 2022, then slumped by 99.98% to $62.0 in 2023, then jumped by 1420.97% to $943.0 in 2024, then jumped by 2869.25% to $28000.0 in 2025, then surged by 7506.68% to $2.1 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q1 2026), $28000.0 (Q4 2025), and $461341.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 163.35 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 204.71 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 84.41 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 78.62 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 128.29 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 187.01 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 191.67 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 124.15 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 45.32 Mn |
| 10 | Aclarion | 6.68 Mn | -12.07 Mn | 3,750.00 | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 461,341.00 |
| Jun 30, 2025 | 582,371.00 |
| Mar 31, 2025 | 219,366.00 |
| Dec 31, 2024 | 943.00 |
| Sep 30, 2024 | 1,043.00 |
| Jun 30, 2024 | 908.00 |
| Mar 31, 2024 | 602.00 |
| Dec 31, 2023 | 62.00 |
| Sep 30, 2023 | 515,975.00 |
| Jun 30, 2023 | 507,499.00 |
| Mar 31, 2023 | 496,159.00 |
| Dec 31, 2022 | 381,598.00 |
| Sep 30, 2022 | 5.52 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 905,685.00 |
| Dec 31, 2021 | 905,685.00 |
| Sep 30, 2021 | 905,685.00 |
| Jun 30, 2021 | 905,685.00 |